ReP USP - Resultado da busca

Artigo de periodico
Primary splenic angiosarcoma: a rare entity often associated with rupture and hemoperitoneum (2019)
Fiorentino, Matheus Dalben; Monteiro, Jean Michel Correia; Siqueira, Renata Elisie Barbalho de; Kim, Elizabeth In Myung; Curi, Ana Paula; Ferreira, Cristiane Rúbia; Nardo, Mirella; Campos, Fernando Peixoto Ferraz de
Fonte: Autopsy and Case Reports. Unidade: HU
Assuntos: BAÇO, DOENÇAS SANGUÍNEAS E LINFÁTICAS, NEOPLASIAS, HEMANGIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FIORENTINO, Matheus Dalben et al. Primary splenic angiosarcoma: a rare entity often associated with rupture and hemoperitoneum. Autopsy and Case Reports, v. 9, n. 3, p. jul./se 2019, 2019Tradução . . Disponível em: https://doi.org/10.4322/acr.2019.100. Acesso em: 03 maio 2024.
APA
Fiorentino, M. D., Monteiro, J. M. C., Siqueira, R. E. B. de, Kim, E. I. M., Curi, A. P., Ferreira, C. R., et al. (2019). Primary splenic angiosarcoma: a rare entity often associated with rupture and hemoperitoneum. Autopsy and Case Reports, 9( 3), jul./se 2019. doi:10.4322/acr.2019.100
NLM
Fiorentino MD, Monteiro JMC, Siqueira REB de, Kim EIM, Curi AP, Ferreira CR, Nardo M, Campos FPF de. Primary splenic angiosarcoma: a rare entity often associated with rupture and hemoperitoneum [Internet]. Autopsy and Case Reports. 2019 ; 9( 3): jul./se 2019.[citado 2024 maio 03 ] Available from: https://doi.org/10.4322/acr.2019.100
Vancouver
Fiorentino MD, Monteiro JMC, Siqueira REB de, Kim EIM, Curi AP, Ferreira CR, Nardo M, Campos FPF de. Primary splenic angiosarcoma: a rare entity often associated with rupture and hemoperitoneum [Internet]. Autopsy and Case Reports. 2019 ; 9( 3): jul./se 2019.[citado 2024 maio 03 ] Available from: https://doi.org/10.4322/acr.2019.100
Trabalho de evento-resumo periodico
Real-life experience of Trastuzumab use among 806 breast cancer patients: role of routine serial echocardiography for the evaluation of asymptomatic ventricular dysfunction in the first 6 months of Trastuzumab therapy (2019)
Silva, Carolina M P D Carvalho; Bittencourt, Márcio Sommer; Santos, Marilia; Bittar, Cristina; Fonseca, Silvia; Pinto, Giovanni; Costa, Isabela; Figueiredo, Clara; Siqueira, Julio; Bond, Marina; Neto, Paulo; Gonzalez, Thalita; Testa, Laura; Hoff, Paulo; Kalil-Filho, Roberto; Hajjar, Ludhmila
Fonte: Journal of the American College of Cardiology. Nome do evento: Annual Scientific Sessions ACC 19: The American College of Cardiology. Unidade: HU
Assuntos: NEOPLASIAS MAMÁRIAS, QUIMIOTERAPIA ADJUVANTE, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Carolina M P D Carvalho et al. Real-life experience of Trastuzumab use among 806 breast cancer patients: role of routine serial echocardiography for the evaluation of asymptomatic ventricular dysfunction in the first 6 months of Trastuzumab therapy. Journal of the American College of Cardiology. New York: Hospital Universitário, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/s0735-1097(19)31285-9. Acesso em: 03 maio 2024. , 2019
APA
Silva, C. M. P. D. C., Bittencourt, M. S., Santos, M., Bittar, C., Fonseca, S., Pinto, G., et al. (2019). Real-life experience of Trastuzumab use among 806 breast cancer patients: role of routine serial echocardiography for the evaluation of asymptomatic ventricular dysfunction in the first 6 months of Trastuzumab therapy. Journal of the American College of Cardiology. New York: Hospital Universitário, Universidade de São Paulo. doi:10.1016/s0735-1097(19)31285-9
NLM
Silva CMPDC, Bittencourt MS, Santos M, Bittar C, Fonseca S, Pinto G, Costa I, Figueiredo C, Siqueira J, Bond M, Neto P, Gonzalez T, Testa L, Hoff P, Kalil-Filho R, Hajjar L. Real-life experience of Trastuzumab use among 806 breast cancer patients: role of routine serial echocardiography for the evaluation of asymptomatic ventricular dysfunction in the first 6 months of Trastuzumab therapy [Internet]. Journal of the American College of Cardiology. 2019 ; 73( 9): 677.[citado 2024 maio 03 ] Available from: https://doi.org/10.1016/s0735-1097(19)31285-9
Vancouver
Silva CMPDC, Bittencourt MS, Santos M, Bittar C, Fonseca S, Pinto G, Costa I, Figueiredo C, Siqueira J, Bond M, Neto P, Gonzalez T, Testa L, Hoff P, Kalil-Filho R, Hajjar L. Real-life experience of Trastuzumab use among 806 breast cancer patients: role of routine serial echocardiography for the evaluation of asymptomatic ventricular dysfunction in the first 6 months of Trastuzumab therapy [Internet]. Journal of the American College of Cardiology. 2019 ; 73( 9): 677.[citado 2024 maio 03 ] Available from: https://doi.org/10.1016/s0735-1097(19)31285-9
Artigo de periodico
Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial (2018)
Avila, Mônica Samuel; Ayub-Ferreira, Silvia Moreira; Wanderley Júnior, Mauro Rogerio de Barros; Cruz, Fatima das Dores; Brandão, Sara Michelly Gonçalves; Rigaud, Vagner Oliveira Carvalho; Santos, Marília Harumi Higuchi dos; Hajjar, Ludhmila Abrahão; Kalil Filho, Roberto; Hoff, Paulo Marcelo; Sahade, Marina; Ferrari, Marcela S M; Costa, Romulo Leopoldo de Paula; Mano, Max Senna; Cruz, Cecília Beatriz Bittencourt Viana; Abduch, Maria Cristina; Alves, Marco Stephan Lofrano; Guimarães, Guilherme Veiga; Issa, Victor Sarli; Bittencourt, Márcio Sommer; Bocchi, Edimar Alcides
Fonte: Journal of the American College of Cardiology. Unidade: HU
Assuntos: CARDIOPATIAS, BETA-BLOQUEADORES, HIDROCARBONETOS POLICÍCLICOS, QUIMIOTERAPIA, TOXICOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AVILA, Mônica Samuel et al. Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial. Journal of the American College of Cardiology, v. 71, n. 20, p. 2281-2290, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.02.049. Acesso em: 03 maio 2024.
APA
Avila, M. S., Ayub-Ferreira, S. M., Wanderley Júnior, M. R. de B., Cruz, F. das D., Brandão, S. M. G., Rigaud, V. O. C., et al. (2018). Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial. Journal of the American College of Cardiology, 71( 20), 2281-2290. doi:10.1016/j.jacc.2018.02.049
NLM
Avila MS, Ayub-Ferreira SM, Wanderley Júnior MR de B, Cruz F das D, Brandão SMG, Rigaud VOC, Santos MHH dos, Hajjar LA, Kalil Filho R, Hoff PM, Sahade M, Ferrari MSM, Costa RL de P, Mano MS, Cruz CBBV, Abduch MC, Alves MSL, Guimarães GV, Issa VS, Bittencourt MS, Bocchi EA. Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial [Internet]. Journal of the American College of Cardiology. 2018 ; 71( 20): 2281-2290.[citado 2024 maio 03 ] Available from: https://doi.org/10.1016/j.jacc.2018.02.049
Vancouver
Avila MS, Ayub-Ferreira SM, Wanderley Júnior MR de B, Cruz F das D, Brandão SMG, Rigaud VOC, Santos MHH dos, Hajjar LA, Kalil Filho R, Hoff PM, Sahade M, Ferrari MSM, Costa RL de P, Mano MS, Cruz CBBV, Abduch MC, Alves MSL, Guimarães GV, Issa VS, Bittencourt MS, Bocchi EA. Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial [Internet]. Journal of the American College of Cardiology. 2018 ; 71( 20): 2281-2290.[citado 2024 maio 03 ] Available from: https://doi.org/10.1016/j.jacc.2018.02.049
Trabalho de evento-resumo periodico
Cardiovascular mortality and myocardial infarction after radiation therapy for left versus right sided breast cancer: a meta-analysis (2016)
Bittencourt, Márcio Sommer; Vecsey-Nagy, Milan; Santos, Marilia; Silva, Carolina; Fonseca, Silvia M; Bittar, Cristina S; Hoff, Paulo G; Kalil-Filho, Roberto; Hajjar, Ludhmila A
Fonte: Journal of the American College of Cardiology. Nome do evento: Annual Scientific Session and Expo - American College of Cardiology. Unidade: HU
Assuntos: NEOPLASIAS MAMÁRIAS, MORTALIDADE, INFARTO DO MIOCÁRDIO, RADIOTERAPIA, REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTENCOURT, Márcio Sommer et al. Cardiovascular mortality and myocardial infarction after radiation therapy for left versus right sided breast cancer: a meta-analysis. Journal of the American College of Cardiology. New York: Hospital Universitário, Universidade de São Paulo. Disponível em: http://www-sciencedirect-com.ez67.periodicos.capes.gov.br/science/journal/07351097/67/13/supp/S. Acesso em: 03 maio 2024. , 2016
APA
Bittencourt, M. S., Vecsey-Nagy, M., Santos, M., Silva, C., Fonseca, S. M., Bittar, C. S., et al. (2016). Cardiovascular mortality and myocardial infarction after radiation therapy for left versus right sided breast cancer: a meta-analysis. Journal of the American College of Cardiology. New York: Hospital Universitário, Universidade de São Paulo. Recuperado de http://www-sciencedirect-com.ez67.periodicos.capes.gov.br/science/journal/07351097/67/13/supp/S
NLM
Bittencourt MS, Vecsey-Nagy M, Santos M, Silva C, Fonseca SM, Bittar CS, Hoff PG, Kalil-Filho R, Hajjar LA. Cardiovascular mortality and myocardial infarction after radiation therapy for left versus right sided breast cancer: a meta-analysis [Internet]. Journal of the American College of Cardiology. 2016 ; 67( 13 supl.): 1512.[citado 2024 maio 03 ] Available from: http://www-sciencedirect-com.ez67.periodicos.capes.gov.br/science/journal/07351097/67/13/supp/S
Vancouver
Bittencourt MS, Vecsey-Nagy M, Santos M, Silva C, Fonseca SM, Bittar CS, Hoff PG, Kalil-Filho R, Hajjar LA. Cardiovascular mortality and myocardial infarction after radiation therapy for left versus right sided breast cancer: a meta-analysis [Internet]. Journal of the American College of Cardiology. 2016 ; 67( 13 supl.): 1512.[citado 2024 maio 03 ] Available from: http://www-sciencedirect-com.ez67.periodicos.capes.gov.br/science/journal/07351097/67/13/supp/S

Unidades USP

ReP

Filtros

Autores

Assuntos

Indexado em